Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity.

Malley R, Anderson PW.

Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3623-7. doi: 10.1073/pnas.1121383109. Epub 2012 Feb 2. Review.

2.

Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development.

Malley R.

J Mol Med (Berl). 2010 Feb;88(2):135-42. doi: 10.1007/s00109-009-0579-4. Epub 2010 Jan 5. Review.

PMID:
20049411
3.

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.

Pletz MW, Maus U, Krug N, Welte T, Lode H.

Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Epub 2008 Apr 18. Review.

PMID:
18378430
4.

Pneumococcal conjugate vaccine for young children.

Selman S, Hayes D, Perin LA, Hayes WS.

Manag Care. 2000 Sep;9(9):49-52, 54, 56-7 passim. Review.

5.

[Pneumococcal surface protein A and new approaches for pneumococcal vaccine development].

Vorob'ev DS, Semenova IB.

Zh Mikrobiol Epidemiol Immunobiol. 2011 Nov-Dec;(6):107-13. Review. Russian.

PMID:
22308742
6.

Systemic and mucosal protective immunity to pneumococcal surface protein A.

Briles DE, Tart RC, Wu HY, Ralph BA, Russell MW, McDaniel LS.

Ann N Y Acad Sci. 1996 Oct 25;797:118-26. Review.

PMID:
8993356
7.
8.

Novel vaccine strategies with protein antigens of Streptococcus pneumoniae.

Swiatlo E, Ware D.

FEMS Immunol Med Microbiol. 2003 Aug 18;38(1):1-7. Review.

9.

Otitis media: the chinchilla model.

Giebink GS.

Microb Drug Resist. 1999 Spring;5(1):57-72. Review.

PMID:
10332723
11.

Pneumococcal vaccine.

Rubin LG.

Pediatr Clin North Am. 2000 Apr;47(2):269-85, v. Review.

PMID:
10761504
12.

Protective immunity of pneumococcal glycoconjugates.

Lee CJ, Lee LH, Frasch CE.

Crit Rev Microbiol. 2003;29(4):333-49. Review.

PMID:
14636043
13.

[Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance].

Pletz MW, Maus U, Hohlfeld JM, Lode H, Welte T.

Dtsch Med Wochenschr. 2008 Feb;133(8):358-62. doi: 10.1055/s-2008-1046719. Review. German.

PMID:
18270917
14.

Immunity to Streptococcus pneumoniae: Factors affecting production and efficacy.

Casal J, Tarragó D.

Curr Opin Infect Dis. 2003 Jun;16(3):219-24. Review.

PMID:
12821811
15.

Advances in pneumococcal vaccines: advantages for infants and children.

Bernatoniene J, Finn A.

Drugs. 2005;65(2):229-55. Review.

PMID:
15631543
16.
17.

Strategies for the control of pneumococcal diseases.

Mulholland K.

Vaccine. 1999 Jul 30;17 Suppl 1:S79-84. Review.

PMID:
10471187
18.

[Proteins of Streptococcus pneumoniae: perspectives for development of pneumococcal vaccine].

Vorob'ev DS, Semenova IB, Kurbatova EA.

Zh Mikrobiol Epidemiol Immunobiol. 2010 Nov-Dec;(6):98-104. Review. Russian.

PMID:
21384595
19.

Contributions of humoral and cellular immunity to vaccine-induced protection in humans.

Amanna IJ, Slifka MK.

Virology. 2011 Mar 15;411(2):206-15. doi: 10.1016/j.virol.2010.12.016. Epub 2011 Jan 8. Review.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk